Article Versions Notes

El fadili M, Er-rajy M, Imtara H, Kara M, Zarougui S, Altwaijry N, Al kamaly O, Al Sfouk A, Elhallaoui M. 3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists. Processes. 2022; 10(8):1462. https://doi.org/10.3390/pr10081462

El fadili, Mohamed, Mohammed Er-rajy, Hamada Imtara, Mohammed Kara, Sara Zarougui, Najla Altwaijry, Omkulthom Al kamaly, Aisha Al Sfouk, and Menana Elhallaoui. 2022. "3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists" Processes 10, no. 8: 1462. https://doi.org/10.3390/pr10081462

El fadili, M., Er-rajy, M., Imtara, H., Kara, M., Zarougui, S., Altwaijry, N., Al kamaly, O., Al Sfouk, A., & Elhallaoui, M. (2022). 3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists. Processes, 10(8), 1462. https://doi.org/10.3390/pr10081462